




















Mechanisms of the anti-aging effects of resveratrol 
 
Resveratrol, a natural agent found in grape skins, has 
been proposed to account for the beneficial effects of 
red wine against heart disease. Resveratrol prevents 
age-related diseases and extends lifespan in several 
species [1-9]. In this issue of Aging, Armour et al 
demonstrate that resveratrol directly inhibits S6 kinase 
(S6K) [10].  
 
S6K is a downstream target of mTOR (mammalian 
Target of Rapamycin). In response to nutrients, growth 
factors and hormones, the mTOR/S6K pathway 
promotes cellular mass growth, which is needed for cell 
proliferation. In post-mitotic (non-proliferating) cells, 
mTOR promotes cellular senescence [11]. Rapamycin 
decelerates mammalian cell senescence [12]. 
Dephosphorylation of S6 is correlated with suppression 
of cellular aging by several agents [13-15]. 
Furthermore, inhibition of the TOR/S6K extends life 
span in yeast, worms and Drosophila [16-21]. Also, 
mice deficient for mTORC1 or S6K are protected 
against obesity [22, 23]. Therefore, the discovery made 
by the David Sinclair laboratory [10] that resveratrol 
directly inhibits S6K is very important.  
 
In addition, resveratrol activates sirtuins [2, 24-25] and 
AMPK [6, 26], which may antagonize the TOR 
pathway downstream and upstream, respectively 
(Figure 1). It has been suggested that sirtuins and 
mTOR may be involved in the same longevity pathway 







































rol may exert its anti-aging effect. But why would 
plants produce an anti-aging drug?  
 
Purpose of anti-aging effects of resveratrol 
 
As suggested by David Sinclair and co-authors in their 
elegant xenohormesis hypothesis, by sensing 
resveratrol, animals can monitor their environment [28, 
29]. Resveratrol is produced by plants in response to 
stress. According to the 'xenohormesis hypothesis', 
organisms have evolved to respond to stress signaling 
molecules produced by other species. In this way, 
organisms can prepare in advance for a deteriorating 
environment and loss of food supply [28, 29]. 
 
The discovery that resveratrol inhibits S6K further 
supports this hypothesis, because S6K is a part of the 
nutrient-sensing pathway. In other words, organisms 
‘sense’ the lack of nutrients before there is an actual 
decline in nutrients.  
 
Here I propose an alternative (but not mutually 
exclusive) model, suggesting that anti-aging effects of 
resveratrol are ‘side effects’ of its cytostatic effect. 
Given that the nutrient-sensing TOR/S6K pathway 
promotes cellular growth, plants produce resveratrol to 
inhibit fungal growth, thus protecting the grape. But the 
same S6K that drives growth also drives aging. In a 
recent issue of Aging, Michael Hall and I discussed how 
growth and aging are hardwired that suppression of 
growth also suppresses aging [30]. By inhibiting S6K, 
resveratrol should slow down both growth and aging.  
Then “the purpose of resveratrol” is to inhibit fungal 
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Using toxins for different purpose 
 
In general, living beings have created numerous 
“medical drugs” for a simple purpose: to harm other 
organisms, to protect themselves from predators, and to 
kill competitors. Plants, microorganisms and sea 
animals produce toxic agents that inhibit or damage 
microtubules, DNA, heat-shock proteins, deacetylases 
and the proteasome, for example. These cytotoxic 
agents are used as anti-cancer drugs, although nature 
did not create them for that purpose. Some agents can 
hurt organisms specifically during developmental 
growth, while sparing adults [31]. Cyclopamine, 
produced by Veratrum californicum (also known as 
western false hellebore, the California state flower), 
inhibits the Wnt/ Hedgehog signaling, essential in some 
cancers. Why would the plant produce such a selective 
anti-cancer drug? Actually, the plant produces a 
teratogen. When pregnant sheep grazed the flower on 
day 14 of gestation newborn lambs had the cyclopic 
defect (one eye in the middle of the face), skeletal and 
cleft palate birth defects [32, 33]. Other plant sources 
contain related alkaloids. Interestingly, pregnant women 
experience nausea and vomiting, which peak during 
weeks 8 to 12. Morning sickness is characterized by 
aversion to strong smelling vegetables [34]. This may 
protect the developing embryo from teratogens 
produced by vegetables and food associated 
microorganisms. Perhaps, females have evolved to 
sense plant xenobiotics [34]. This suggestion is 
analogous to the xenohormesis model. 
 
On the other hand, a target of a xenobiotic could be 
essential early in life and cause aging later in life. And 
TOR is such a target. Its knockout is lethal during 
embryogenesis [35, 36]. Similarly, a double knockout of 
S6K1 and S6K2  is lethal [37]. In yeast, deletion of both 
TOR genes or TOR2 only is lethal [20]. Certainly, TOR 
is a perfect target for an anti-fungal drug. And, in fact, 
soil bacteria produce rapamycin to inhibit yeast growth.  
Thus, rapamycin is a mirror image of penicillin that is 
produced by fungi to inhibit bacterial growth.  
 
Although not created for that purpose by nature, 
inhibitors of mTOR are used as anticancer agents [38]. 
Furthermore, rapamycin prevents cancer in humans 
[39], perhaps, as an ‘anti-aging side effect’ [40]. 
Rapamycin is also indicated for the therapy of almost 
all age-related diseases from atherosclerosis to macular 
degeneration [41, 42]. However, bacteria produce 
rapamycin not as an aging suppressant, nor as a 
medicine for longevity, but rather as a growth 
suppressant. Growth suppressants may suppress aging 
because aging is a continuation of growth, driven by the 
same nutrient sensing TOR/S6K pathway. 
 
Back to resveratrol 
 
Thus, the anti-aging effect of resveratrol may be just a 
side effect of targeting S6K, sirtuins and AMPK. 
However, there are two indirect arguments about why 
animals might have evolved ‘target of resveratrol’ for 
their benefit (in agreement with the xenohormesis 
model). First, resveratrol (unlike rapamycin) has 
multiple targets in the same nutrient-sensing network: 
sirtuins, S6K, AMPK and perhaps several others. Why 
so many? Second, resveratrol toxicity seems to be 
unrelated to these targets. So let us consider a modified 
(taking into account that growth and aging are linked) 
xenohormesis model. Plants produce resveratrol to 
protect grapes from parasites by affecting ‘target X’ (an 
intended target of resveratrol). Levels of resveratrol will 
be raised during plant infections, heralding the 
possibility of famine. Animals thus evolved targets 
inside the TOR/sirtuin network in order to sense 
resveratrol. (Note: The purpose is not to suppress aging. 
In the wild, lifespan is not limited by aging, especially 
during famine.) Perhaps, animals evolved sensors for 
resveratrol in the growth promoting pathway in order to 
inhibit growth. Thus resveratrol (mimicking lack of 
nutrients) can restrain growth of the animal, and a 
smaller animal would need less food during a 
forthcoming famine. But, coincidentally, the inhibition 
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Thus, there are two alternative (but not mutually 
exclusive) models of the ‘natural purpose’ of anti-aging 
drugs. First, according to the xenohormesis model [28, 
29], animals evolved the ability to sense their 
environment in order to modulate their functions, stress 
resistance or growth. This is consistent with there being 
multiple targets for resveratrol exactly in the pathway 
that senses the environment. Second, according to the 
anti-aging side effect model, plants and bacteria 
produce growth suppressants to hurt parasites and 
competitors. Yet, the same growth promoting pathway 
is also involved in aging. In the wild, growth 
suppressants exclusively hurt young organisms by 
inhibiting their developmental growth. In the protected 
environment, when animals live long enough to 
experience aging, the aging suppressant side effect 
becomes apparent.  
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